STOCK TITAN

Braskem posts Recurring EBITDA of US$320 million in the quarter, 39% higher than 1Q24 and 128% higher than 2Q23

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Braskem S.A. (NYSE: BAK) reported significant financial improvements in Q2 2024. The company achieved a Recurring EBITDA of $320 million, which represents a 39% increase from Q1 2024 and a 128% increase from Q2 2023.

Braskem's cash position stands robust at $2.8 billion, ensuring debt maturity coverage over the next five years. Operating cash generation for the quarter was $69 million, a notable rise from both Q1 2024 and Q2 2023.

The Braskem Idesa sector recorded its highest sales volume since Q3 2017, with 233 kton, marking a 12% increase from Q1 2024 and a 9% rise from Q2 2023.

For more detailed insights, investors can access the complete earnings release on Braskem's IR website.

Braskem S.A. (NYSE: BAK) ha riportato miglioramenti finanziari significativi nel secondo trimestre del 2024. L'azienda ha registrato un EBITDA Ricorrente di 320 milioni di dollari, il che rappresenta un 39% di aumento rispetto al primo trimestre del 2024 e un 128% di aumento rispetto al secondo trimestre del 2023.

La posizione di cassa di Braskem è solida a 2,8 miliardi di dollari, garantendo la copertura delle scadenze del debito nei prossimi cinque anni. La generazione di cassa operativa per il trimestre è stata di 69 milioni di dollari, con un notevole aumento rispetto sia al primo trimestre del 2024 che al secondo trimestre del 2023.

Il settore Braskem Idesa ha registrato il suo volume di vendite più alto dal terzo trimestre del 2017, con 233 kton, segnando un aumento del 12% rispetto al primo trimestre del 2024 e un aumento del 9% rispetto al secondo trimestre del 2023.

Per approfondimenti più dettagliati, gli investitori possono accedere al comunicato stampa completo sui risultati finanziari sul sito web delle relazioni con gli investitori di Braskem.

Braskem S.A. (NYSE: BAK) reportó mejoras financieras significativas en el segundo trimestre de 2024. La compañía logró un EBITDA Recorrente de 320 millones de dólares, lo que representa un 39% de aumento en comparación con el primer trimestre de 2024 y un 128% de aumento respecto al segundo trimestre de 2023.

La posición de efectivo de Braskem es sólida con 2.8 mil millones de dólares, garantizando la cobertura de vencimientos de deuda durante los próximos cinco años. La generación de efectivo operativo para el trimestre fue de 69 millones de dólares, un aumento notable respecto tanto al primer trimestre de 2024 como al segundo trimestre de 2023.

El sector Braskem Idesa registró su mayor volumen de ventas desde el tercer trimestre de 2017, con 233 kton, lo que marca un aumento del 12% en comparación con el primer trimestre de 2024 y un aumento del 9% respecto al segundo trimestre de 2023.

Para obtener información más detallada, los inversionistas pueden acceder al comunicado de ganancias completo en el sitio web de relaciones con inversionistas de Braskem.

Braskem S.A. (NYSE: BAK)는 2024년 2분기에 상당한 재무 개선을 보고했습니다. 회사는 3억 2천만 달러지속 가능 EBITDA를 달성했으며, 이는 2024년 1분기 대비 39% 증가한 수치이며 2023년 2분기 대비 128% 증가한 것입니다.

Braskem의 현금 위치는 28억 달러로 견고하게 유지되고 있으며, 향후 5년간의 부채 만기 대처를 보장합니다. 이번 분기의 운영 현금 생성은 6,900만 달러로, 2024년 1분기와 2023년 2분기 모두에서 주목할 만한 증가를 보였습니다.

Braskem Idesa 부문은 2017년 3분기 이후 최대 판매량인 233 kton을 기록하였으며, 이는 2024년 1분기 대비 12% 증가하고 2023년 2분기 대비 9% 상승한 수치입니다.

보다 자세한 정보는 투자자들이 Braskem의 IR 웹사이트에서 전체 실적 발표를 확인할 수 있습니다.

Braskem S.A. (NYSE: BAK) a rapporté des améliorations financières significatives au deuxième trimestre de 2024. L'entreprise a enregistré un EBITDA Récurrent de 320 millions de dollars, représentant une augmentation de 39% par rapport au premier trimestre de 2024 et une augmentation de 128% par rapport au deuxième trimestre de 2023.

La position de liquidités de Braskem est solide avec 2,8 milliards de dollars, garantissant ainsi la couverture des échéances de la dette au cours des cinq prochaines années. La génération de trésorerie opérationnelle pour le trimestre s'est élevée à 69 millions de dollars, une hausse notable par rapport au premier trimestre 2024 et au deuxième trimestre 2023.

Le secteur Braskem Idesa a enregistré son plus grand volume de ventes depuis le troisième trimestre 2017, avec 233 kton, marquant une augmentation de 12% par rapport au premier trimestre de 2024 et une augmentation de 9% par rapport au deuxième trimestre de 2023.

Pour des informations plus détaillées, les investisseurs peuvent accéder au communiqué complet des résultats sur le site IR de Braskem.

Braskem S.A. (NYSE: BAK) berichtete über signifikante finanzielle Verbesserungen im zweiten Quartal 2024. Das Unternehmen erzielte ein wiederkehrendes EBITDA von 320 Millionen US-Dollar, was einem 39% Anstieg im Vergleich zum ersten Quartal 2024 und einem 128% Anstieg im Vergleich zum zweiten Quartal 2023 entspricht.

Die Liquiditätsposition von Braskem ist stark bei 2,8 Milliarden US-Dollar, was die Deckung von Schuldenfälligkeiten für die nächsten fünf Jahre sichert. Die operative Cashgenerierung für das Quartal betrug 69 Millionen US-Dollar, was einen bemerkenswerten Anstieg im Vergleich zu sowohl Q1 2024 als auch Q2 2023 darstellt.

Der Sektor Braskem Idesa verzeichnete das höchste Verkaufsvolumen seit Q3 2017 mit 233 kton, was einen Anstieg von 12% im Vergleich zu Q1 2024 und einen Anstieg von 9% im Vergleich zu Q2 2023 markiert.

Für detailliertere Einblicke können Investoren die vollständige Ergebnisveröffentlichung auf der IR-Website von Braskem einsehen.

Positive
  • Recurring EBITDA increased by 39% from Q1 2024 and 128% from Q2 2023.
  • Strong cash position of $2.8 billion.
  • Operating cash generation improved to $69 million.
  • Braskem Idesa posted its best sales performance since Q3 2017, with sales volume up 12% from Q1 2024 and 9% from Q2 2023.
Negative
  • None.

Insights

Braskem's Q2 2024 results show a significant turnaround, with Recurring EBITDA surging to $320 million, marking impressive growth of 39% quarter-over-quarter and 128% year-over-year. This substantial improvement suggests a robust recovery in the petrochemical sector.

The company's strong cash position of $2.8 billion is a key highlight, providing ample liquidity to cover debt obligations for the next five years. This financial stability is important in the cyclical chemicals industry, offering a buffer against market volatility.

The positive Operating Cash Generation of $69 million represents a significant swing from previous quarters, indicating improved operational efficiency and working capital management. Braskem Idesa's record sales volume since Q3 2017 further underscores the company's operational strength and market demand recovery.

Braskem's impressive Q2 performance signals a potential inflection point in the petrochemical market. The 128% year-over-year EBITDA growth suggests a substantial improvement in industry dynamics, likely driven by recovering demand and favorable pricing spreads.

The strong sales performance of Braskem Idesa, reaching a 7-year high at 233 kton, indicates robust demand in the Mexican market and potentially wider Latin America. This could be a leading indicator of broader economic recovery in the region.

However, investors should remain cautious. While the results are encouraging, the petrochemical industry is known for its cyclicality. It's important to monitor whether this performance is sustainable or if it represents a peak in the current cycle. The company's strong liquidity position does provide a safety net for navigating potential future market volatility.

SÃO PAULO, Aug. 8, 2024 /PRNewswire/ -- BRASKEM S.A. (B3: BRKM3, BRKM5 and BRKM6; NYSE: BAK; LATIBEX: XBRK) the largest resin producer in the Americas and the world's leading biopolymers producer, presents its 2Q24 Earnings Release.

2Q24 HIGHLIGHTS
CONSOLIDATED

  • Recurring EBITDA of US$320 million, around R$1,667million, higher than 1Q24 (+39%) and 2Q23 (+128%).
  • Cash position of US$2.8 billion, ensuring coverage of debt maturities over the next 5 years.
  • Operating Cash Generation¹ of US$69 million, around R$357 million, higher than 1Q24 (+US$170 MM) and 2Q23 (+US$82 MM).
  • Braskem Idesa Sales: Best Sales performance since 3Q17, with sales volume of 233 kton, higher than 1Q24 (+12%) and 2Q23 (+9%)

The full earnings release is available on the Company's IR website: www.braskem-ri.com.br/en

Braskem will host conference calls to discuss its Results Thursday, August 8 at 10:00 a.m. US ET.

Additional information may be obtained from the Investor Relations Department at +55 11 3576-9531 or braskem-ri@braskem.com.br.

1 Cash Flow Generation (=) Net Cash Generated from Operating Activities (-) Leniency Agreement (+) effects of
reclassifications between the lines of Financial Investments (includes LFT's and LF's) and Cash and Cash Equivalents (+)
Net Cash used in Investing Activities (+) Leasing.

 

Cision View original content:https://www.prnewswire.com/news-releases/braskem-posts-recurring-ebitda-of-us320-million-in-the-quarter-39-higher-than-1q24-and-128-higher-than-2q23-302218048.html

SOURCE Braskem

FAQ

What was Braskem's Recurring EBITDA for Q2 2024?

Braskem's Recurring EBITDA for Q2 2024 was $320 million.

By how much did Braskem's Recurring EBITDA increase from Q1 2024?

Braskem's Recurring EBITDA increased by 39% from Q1 2024.

What is Braskem's current cash position as of Q2 2024?

As of Q2 2024, Braskem's cash position is $2.8 billion.

How much did Braskem's operating cash generation improve in Q2 2024?

Braskem's operating cash generation improved to $69 million in Q2 2024.

What was the sales volume for Braskem Idesa in Q2 2024?

The sales volume for Braskem Idesa in Q2 2024 was 233 kton.

When will Braskem host conference calls to discuss its Q2 2024 results?

Braskem will host conference calls on Thursday, August 8 at 10:00 a.m. US ET.

Braskem S.A. American Depositary Shares (Each representing Two

NYSE:BAK

BAK Rankings

BAK Latest News

BAK Stock Data

2.03B
398.48M
6.33%
0.39%
Chemicals
Basic Materials
Link
United States of America
São Paulo